NATCAPSUQNSENatural Capsules LimitedLowNeutral
Announced Tue, 5 Aug · 19:53 IST

Natural Capsules Limited has informed the Exchange regarding voting results of Annual General Meeting held on August 04, 2025

Board & Shareholder Meetings View source PDF

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Natural Capsules Limited held its 32nd Annual General Meeting on August 4, 2025, via video conferencing from 11:30 AM to 12:20 PM, and all 8 resolutions were passed unanimously. Out of 1.03 crore total shares, 53.14 lakh shares (51.39%) were polled, with 100% votes in favor and zero against on every resolution. The resolutions covered: adoption of FY25 audited financial statements, re-appointment of two retiring directors (Sathyanarayana Mundra and Sushil Kumar Mundra), continuation of independent director Tekkar Yashwanth Prabhu beyond age 75, reappointment of Sathyanarayana Mundra as Whole-time Director with revised remuneration, appointment of a secretarial auditor for 5 years, related party transactions with subsidiary Natural Biogenex Private Limited (promoters abstained from voting), and commission payment to non-executive directors. Promoters hold 53.01 lakh shares (51.26%) and the public holds 50.40 lakh shares, but only 0.66% of public shares were voted. Out of 9,508 total shareholders, just 35 attended (12 promoters, 23 public).

Likely market impact

This is a routine post-AGM regulatory disclosure with no negative surprises, as all resolutions including related party transactions and director remuneration revisions passed without any opposition. However, the very low public voting turnout (0.66% of public shares) suggests limited minority shareholder engagement, though this is common for small-cap companies with concentrated promoter holdings.